You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Merck
Baxter
Dow
Harvard Business School

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

Litigation Details for In Re: Testosterone Replacement Therapy Products Liability Litigation (N.D. Ill. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in In Re: Testosterone Replacement Therapy Products Liability Litigation
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for In Re: Testosterone Replacement Therapy Products Liability Litigation (N.D. Ill. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-11-23 1074 other filed U.S. Patent No. 6,503,894 (“the ‘894 Patent”) with the U.S. Patent Office for pharmaceutical…AndroGel that is registered with the United States Patent and Trademark Office. 24. Defendant … b. Besins Inc. holds the U.S. patent for the pharmaceutical formulation …property right to it. Acrux DDS Pty Ltd. owns the patents for Axiron. Acrux is thus also sued in connection….” d. On January 7, 2003, the ’894 Patent was issued to Unimed and Besins as External link to document
2015-05-22 777 other . filed U.S. Patent No. 6,503,894 (“the ‘894 Patent”) with the U.S. Patent Office for pharmaceutical…AndroGel that is registered with the United States Patent and Trademark Office. 24. Defendant Solvay… b. Besins Inc. holds the U.S. patent for the pharmaceutical formulation …property right to it. Acrux DDS Pty Ltd. owns the patents for Axiron. Acrux is thus also sued in connection…Hypogonadism.” d. On January 7, 2003, the ’894 Patent was issued to Unimed and Besins as co- External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Merck
AstraZeneca
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.